Psychiatric issues in pulmonary disease

Psychiatric Clinics of North America

Volumn 25, Issue 1, 2002, Pages 89-127

  Coffman, Kathy ^a  

^a ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; CYCLOSPORIN; DEXTROMETHORPHAN; DIAZEPAM; DONEPEZIL; FAMOTIDINE; HALOPERIDOL; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; MONTELUKAST; NEFAZODONE; NORDAZEPAM; OMEPRAZOLE; PAROXETINE; PROTRIPTYLINE; PSYCHOTROPIC AGENT; RANITIDINE; RIFAMPICIN; RISPERIDONE; STEROID; TERBUTALINE; THEOPHYLLINE; THIORIDAZINE; TOPIRAMATE; UNINDEXED DRUG; VENLAFAXINE;

ANXIETY NEUROSIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEPRESSION; DISEASE EXACERBATION; DRUG INDUCED DISEASE; HUMAN; HYPERVENTILATION; LUNG DISEASE; LUNG TRANSPLANTATION; MEDICAL DECISION MAKING; MENTAL DISEASE; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SURVIVAL;

EID: 0036208119     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(03)00054-6     Document Type: Review

References (226)

1. Assessment of quality of life by clinicians: Experience of a practical method in lung cancer patients
2. Asthma patients and their partners: Gender differences in the relationship between psychological distress and patient functioning
3. Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B
4. Predictive factors for psychological distress in ambulatory lung cancer patients
5. Change in quality of life after lung volume reduction surgery
6. "Terminal" wean is the wrong term
7. Mass psychogenic systemic illness in school children in relation to the Tokyo photochemical smog
8. Lung transplantation
9. Chronic diffuse interstitial fibrosis of the lung in uranium miners
10. The effect of panresistant bacteria in cystic fibrosis patients on lung transplant outcome
11. Adductor spastic dysphonia
12. Hirschsprung disease and primary central hyperventilation syndrome: A new form of neurocristopathy
13. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation
14. Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management
15. Difficult asthma
16. Recipient and donor outcomes in living related and unrelated lobar transplantation
17. Hyperventilation syndrome: A chimera?
18. Limitations of spirometry in detecting rejection after single-lung transplantation
19. Terminal weaning: A loved one's vigil
20. Depression among children with chronic medical problems
21. Psychosocial issues in the treatment of patient with lung cancer
22. Structure and expression of the promoter for the R4/ALK5 hu type I transforming growth factor-beta receptor: Regulation by TGF-beta
23. The pathology of interstitial lung disease in nylon flock workers
24. Hyperventilation syndrome: Clinical, ventilatory, personality characteristics as observed in neurological practice
25. Withdrawing intensive life-sustaining treatment: Recommendations for compassionate clinical management
26. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis
27. The hyperventilation syndrome as psychosomatic components of heart transplantation: Case study
28. Integrating technology with compassionate care: Withdrawal of ventilation in a conscious patient with apnea
29. Terminal weaning: It's not simply "pulling the plug."
30. Chronic hyperventilation syndrome associated with syncope and coronary vasospasm
31. Psychological issues in the treatment of asthmatic patients
32. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation
33. Temporal differences in coping, mood, and stress with chemotherapy
34. Hypoxaemia in patients with hyperventilation syndrome
35. The child's eye: Memories of growing up with cystic fibrosis
36. Primary graft failure following lung transplantation
37. Vocal-cord dysfunction presenting as asthma
38. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts
39. Neuro-ophthalmic complications of sarcoidosis
40. Hypnotic examination of trigger factors in the hyperventilation syndrome
41. A Nursing model for chronic illness management based upon the trajectory framework
42. Surgery for chronic obstructive pulmonary disease: The place for lung volume reduction and transplantation
43. Hyperventilation and panic disorder
44. Buspirone for anxiety disorders in patients with severe lung disease
45. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease
46. Medical compliance and coping with cystic fibrosis
47. Withdrawal of mechanical ventilation: Ethical principles and guidelines for terminal weaning
48. The impact of cytolytic therapy on bronchiolitis obliterans syndrome
49. Hyperventilation syndrome and the assessment of treatment for functional cardiac symptoms
50. Breathing retraining: A three-year follow-up study of treatment for hyperventilation syndrome and associated functional cardiac symptoms
51. The hyperventilation syndrome in panic disorder, agoraphobia and generalized anxiety disorder
52. Somatization disorder in a University Hospital
53. Neurologic manifestations in sarcoidosis
54. Hyperventilation syndrome and asthma
55. Factitious asthma: Physiological approach to diagnosis
56. Psychiatric aspects of patients with chronic obstructive pulmonary disease
57. Neurotic neuromuscular and autonomic nervous for of magnesium imbalance
58. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients
59. Sedation before ventilator withdrawal
60. Successful double-lung transplantation for bronchioalveolar carcinoma
61. Gemcitabine/Alimta in locally advanced or metastatic non-small-cell lung cancer
62. The clinical management of dying patients receiving mechanical ventilation: A survey of physician practice
63. Do psychological factors modify survival of cancer patients? II. Results of an empirical study with bronchial carcinoma patients
64. Coping, distress and survival among patients with lung cancer
65. Causal "cancer personality" attribution: An expression of maladaptive coping with illness?
66. Group treatment of the hyperventilation syndrome
67. Vestibular hyperreactivity and hyperventilation after whiplash injury
68. The pathophysiology of hyperventilation syndrome
69. Are coronary artery spasm and progressive damage to the heart associated with the hyperventilation syndrome?
70. Depression and asthma in children
71. Idiopathic pulmonary fibrosis: Predicting response to therapy and survival
72. Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer
73. Risk factors for the development of obliterative bronchiolitis after lung transplantation
74. Internal medicine and medical subspecialties
75. "Terminal weaning": Discontinuance of life-support therapy in the terminally ill patient
76. Cognitive behavioral interventions for adolecents with cystic fibrosis
77. Lung volume reduction surgery: A survey on the European experience
78. Hyperventilation syndrome
79. Procurement and allocation of solid organs for transplantation
80. Review of immunosuppression for lung transplantation: Novel drugs, new uses for conventional immunosuppressants, and alternative strategies
81. Behavioral treatment of angina-like chest pain in patients with hyperventilation syndrome
82. Hypocalcemic crisis: Hypoparathyroidism-non-parathyroid origin. The most frequent form: Hyperventilation syndrome
83. Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors
84. Biomedical ethics and the withdrawal of advanced life support
85. Lung volume reduction surgery for diffuse emphysema
86. Clinical characteristics and outcome of 508 patients with hyperventilation syndrome
87. Adolescent hyperventilation syndrome
88. Syncope due to right atrial thromboembolism: Diagnostic importance of two-dimensional echocardiography
89. Hyperventilation and panic attacks
90. Quality of life during clinical trials: Conceptual model for the Lung Cancer Symptoms Scale (LCSS)
91. Sarcoidosis with involvement of the nervous system: Report of nine cases
92. Quality of life assessment in chemotherapy trials for non-small cell lung cancer: Are theory and practice significantly different?
93. Depression in patients with lung cancer: Prevalence and risk factors derived from quality-of-life data
94. Application of the relaxation technique in general hospital psychiatry
95. The Registry of the International Society for Heart and Lung Transplantation: Fifteenth official report, 1998
96. Medical care of the adolescent with asthma
97. Aerosolized cyclosporine in lung recipients with refractory chronic rejection
98. The effects of suggestion and emotional arousal on pulmonary function in asthma: A review and a hypothesis regarding vagal mediation
99. Long-term survivors of small-cell lung cancer: A French multicenter study
100. A hyperventilation syndrome in a patient with hereditary mesenchmal dysplasia
101. Psychological factors affecting medical condition (psychosomatic disorders): Hyperventilation syndrome
102. Asthma severity, psychophysiological indicators of arousal, and immune function in asthma patients undergoing biofeedback-assisted relaxation
103. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome
104. Loss of pulmonary function gains after lung volume reduction surgery
105. Alpha 1-antitrypsin deficiency and idiopathic pulmonary fibrosis in a family
106. Psychological factors in sarcoidosis: The relationship between life stress and pulmonary function
107. Treatment of panic attacks associated with chronic obstructive pulmonary disease (COPD)
108. Infectious complications in heart-lung transplantation: Analysis in 200 episodes
109. Small cell lung cancer associated with anti-Hu antibody-positive paraneoplastic neurological syndrome
110. Hyperventilation syndrome: Current advances
111. Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy
112. Interstitial fibrosis and growth factors
113. Central hyperventilation related to administration of topiramate
114. Relaxation decreases large-airway but not small-airway asthma
115. The burden of pediatric asthma
116. Differentiation of spasmodic and psychogenic dysphonias with phonoscopic evaluation
117. Recurrent laryngeal nerve section for spasmodic dysphonia
118. Correlation of changes in quality of life after lung volume reduction surgery with changes in lung function, exercise, and gas exchange
119. Periodic breathing imitating hyperventilation syndrome
120. Endocrine diseases and metabolic disorders
121. Endocrine diseases and metabolic disorders
122. CF and me. Interview by Anna Sidey
123. Comparison of clinical results for unilateral and bilateral thoracoscopic lung volume reduction
124. Function of the respiratory system in miners with chronic regional hypobaric hypoxia and hypothermia
125. Lung volume reduction surgery: Results of a Canadian pilot study
126. Effects of depressive symptoms on health-related quality of life in asthma patients
127. Pulmonary involvement in systemic scleroderma: Part I. Chronic fibrosing interstitial lung disease
128. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis
129. Sarcoidosis of the nervous system
130. International guidelines for the selection of lung transplant candidates
131. Effects of buspirone on sleep and respiration
132. Short- and long-term results after lung volume reduction surgery
133. Depressive symptoms in cancer patients undergoing chemotherapy: A psychometric analysis
134. A case of a pituitary mass in association with sarcoidosis
135. Mental disorders induced by arbamazepine
136. Quality of life in patients with lung cancer: A review of literature from 1970 to 1995
137. Mechanisms and models to predict a QTc effect
138. Repressive-defensive style and physiological reactivity among children and adolescents with asthma
139. Pseudoseizures caused by hyperventilation resembling absence epilepsy
140. Redo lung transplantation: A North American-European experience
141. DaCosta's syndrome: Chronic symptomatic hyperventilation
142. Improvements in lung function, exercise, and quality of life in hypercapneic COPD patients after lung volume reduction surgery
143. The current status of lung transplantation: A nursing perspective
144. Sequential changes in bronchoalveolar lavage cells and cytokines in a patient progressing from acute to chronic bird Fancier's lung disease
145. Psychophysiological investigations of patients with unilateral symptoms in the hyperventilation syndrome
146. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation
147. The interrelationship of weight loss, dietary intake, and quality of life in ambulatory patients with cancer of the lung, breast, and ovary
148. Family therapy for asthma in children
149. Saprophytic fungal infections and lung transplantation revisited
150. Return to work after lung transplantation
151. Hyperventilation
152. Neurological manifestations of the hyperventilation syndrome
153. Status epilepticus as a complication of concurrent electroconvulsive and theophylline therapy
154. Mixed hematopoietic chimerism induces donor-specific tolerance for lung allografts in rodents
155. Role of the nurse counselor in managing patients with the hyperventilation syndrome
156. An evaluation of asthma education for school personnel using peak performance USA
157. A study of the relationship among self-reported noncompliance, symptomatology, and psychological variables in patients with asthma
158. Episodic laryngeal dyskinesia: Clinical and psychiatric characterization
159. Differing effects of the anxiolytic agents buspirone and diazepam on control of breathing
160. Cardio-respiratory studies on glass bangle workers
161. Electroconvulsive therapy in patients taking theophylline
162. How to manage primary pulmonary hypertension: Giving hope to patients with a life-threatening illness
163. Video intervention/prevention assessment: A patient-centered methodology for understanding the adolescent illness experience (1)
164. Emotions and stress increased respiratory resistance in asthma
165. A study of spastic dysphonia: Neurologic and electroencephalographic abnormalities
166. A prospective longitudinal investigation of spousal bereavement examining Parkes and Weiss' Bereavement Risk Index
167. Functional somatic complaints in adolescents: Relationship to negative life events, self-concept, and family characteristics
168. Hyperventilation syndrome: Could acute salicylic acid poisoning be the cause?
169. The hyperventilation syndrome in children
170. The hyperventilation syndrome treated with antidepressive agents
171. Patients with acute hyperventilation presenting to an inner-city emergency department
172. Subclinical interstitial lung involvement in rheumatic diseases: Correlation of high-resolution computerized tomography and functional and cytologic findings
173. Tests of the relationship between children's temperament and asthma and of the reliability and validity of the Brief Scale of Temperament
174. Women with lung cancer: Impact on quality of life
175. Medical and psychiatric predictors of airway reactivity
176. Psychosocial factors in carcinogenesis: On the problem of the so-called cancer-prone personality
177. Thalamic hemorrhage imitating hyperventilation
178. Is buspirone effective for panic disorder?
179. Neurologic sarcoidosis
180. Carbon monoxide poisoning presenting as hyperventilation syndrome
181. Perceived uncertainty, physical symptoms, and negative mood in hospitalized patients with chronic obstructive pulmonary disease
182. Panic anxiety in patients with respiratory disease
183. Pseudomonas capacia in lung transplantation recipients with cystic fibrosis
184. How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counseling?
185. Discordance between symptom and physiological criteria for the hyperventilation syndrome
186. Hyperventilation and panic attacks in general hospital patients
187. Development of a brief coping checklist for use with pediatric populations
188. Functional upper airway obstruction: A possible somatization disorder
189. The incidence, aetiology and management of anaphylaxis presenting to an accident and emergency department
190. A study of investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer
191. Functional psychoses in sarcoidosis
192. A case of chronic hyperventilation syndrome effectively treated with metoprolol
193. Psychiatric studies of chemotherapy and chemotherapy-induced nausea and vomiting of patients with lung or thymic cancer
194. Reviewing asthma and anxiety
195. Hyperventilation in a very old woman
196. Short- and long-term functional results after lung volume reduction surgery for severe emphysema
197. Flunarizine treatment in dizzy patients with vestibular hyperactivity and hyperventilation
198. Principles of pharmacokinetics and pharmacodynamics
199. Short term memory deficit in a patient with cerebral carcoidosis
200. Misdiagnosis of diabetic ketoacidosisa hyperventilation syndrome
201. Treatment of the hyperventilation syndrome with bisoprodol: A placebo-controlled clinical trial
202. Lung volume reduction surgery for emphysema: Initial experience at the University hospital Gasthuisberg
203. Asbestosis and silicosis
204. The functional disability inventory: Measuring a neglected dimension of child health status
205. The origins of childhood asthma
206. Beitrag zur Frage der "sarkoide" Resp der subkutanenen nodularen Tuberkulide
207. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation
208. Standard vs palliation chemotherapy in metastatic small cell lung cancer: An analysis on treatment efficacy and quality of life
209. Evolving the biobehavioral family model: The fit of attachment
210. QT interval: A measure of drug action
211. Clinical study on super-long-term survival over 15 years of postoperative patients with lung cancer
212. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study group
213. The prevalence of distress by cancer site
214. Die Meningoencephalitis